Samsung BioLogics covers $2bn IPO on day one

Jonathan Breen

October 18, 2016 04:00 AM

samsung_flags_230px

South Korea’s Samsung BioLogics gathered enough orders from investors to cover its W2.25tr ($2.0bn) IPO after the very first day of bookbuilding.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP Morgan Credit Suisse Equity IPOs Equity Korea Investment and Securities Citi South Korea Asia Northeast Asia Asia Pacific Emerging Markets

JB

Jonathan Breen

Equities editor GlobalCapital Asia